Serenity Bioworks Inc.
$90,000.00 CAD
≈ 14 months of average Canadian pay
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2021-2022
- Agreement period
- May 2, 2021 – March 31, 2022
- Reference
- nrc-cnrc:172-2021-2022-Q2-976913
Published purpose
Serenity Bioworks is conducting drug-development studies to gain a better understanding of the interaction and effectiveness of its lead biotherapeutic in combination with the standard of care drugs in an autoimmune disease, lupus nephritis.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported July 30, 2026 from open.canada.ca Grants & Contributions